Production and Supply of alpha-Particle–Emitting Radionuclides for Targeted alpha-Therapy
Encouraging results from targeted alpha-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review,we discuss themost promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of alpha-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.
RADCHENKO Valery;
MORGENSTERN Alfred;
JALILIAN A.;
RAMOGIDA Catarina;
CUTLER Cathy;
DUCHEMIN Charlotte;
HOEHR Cornelia;
HADDAD Ferid;
BRUCHERTSEIFER Frank;
GAUSEMEL Haavar;
YANG Hua;
OSSO J.;
WASHIYAMA Kohshin;
CZERWISNKI Ken;
LEUFGEN Kristen;
PRUSZYNSKI Marek;
VALZDORF Olga;
CAUSEY Patrick;
SCHAFFER Paul;
PERRON Randy;
SAMSONOV Maxim;
WILBUR Scott;
STORA Thierry;
LI Yawen;
2021-11-16
SOC NUCLEAR MEDICINE INC
JRC124738
0161-5505 (online),
https://jnm.snmjournals.org/content/62/11/1495,
https://publications.jrc.ec.europa.eu/repository/handle/JRC124738,
10.2967/jnumed.120.261016 (online),
Additional supporting files
| File name | Description | File type | |
|---|
